Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip B Hylemon

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2026
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary FibrosisSayed Obaidullah Aseem, Jing Wang, Ahmed Younis, et al.
Journal of Lipid Research|October 3, 2020
Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transitionGenta Kakiyama, Dalila Marques, Rebecca Martin, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acidsPuneet Puri, Kalyani Daita, Andrew Joyce, et al.
Hepatology Communications|February 7, 2018
Gut microbial composition can differentially regulate bile acid synthesis in humanized miceDae Joong Kang, Phillip B Hylemon, Patrick M Gillevet, et al.
Hepatology (Baltimore, Md.)|January 20, 2018
Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohortJasmohan S Bajaj, Ramazan Idilman, Leila Mabudian, et al.
Journal of Hepatology|January 22, 2013
Modulation of the fecal bile acid profile by gut microbiota in cirrhosisGenta Kakiyama, William M Pandak, Patrick M Gillevet, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 27, 2014
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and functionJasmohan S Bajaj, I Jane Cox, Naga S Betrapally, et al.
Plos One|April 9, 2013
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathyJasmohan S Bajaj, Douglas M Heuman, Arun J Sanyal, et al.
Hepatology (Baltimore, Md.)|June 21, 2019
Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal TransplantRunping Liu, Jason D Kang, R Balfour Sartor, et al.
World Journal of Gastroenterology|December 8, 2025
Bile acid dysmetabolism in Bangladeshi infants associated with poor linear growth, enteric inflammation, and small intestine bacterial overgrowthFarah Hasan, Phillip B Hylemon, Rashidul Haque, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|June 4, 2026
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary FibrosisSayed Obaidullah Aseem, Jing Wang, Ahmed Younis, et al.
Journal of Lipid Research|October 3, 2020
Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transitionGenta Kakiyama, Dalila Marques, Rebecca Martin, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acidsPuneet Puri, Kalyani Daita, Andrew Joyce, et al.
Hepatology Communications|February 7, 2018
Gut microbial composition can differentially regulate bile acid synthesis in humanized miceDae Joong Kang, Phillip B Hylemon, Patrick M Gillevet, et al.
Hepatology (Baltimore, Md.)|January 20, 2018
Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohortJasmohan S Bajaj, Ramazan Idilman, Leila Mabudian, et al.
Journal of Hepatology|January 22, 2013
Modulation of the fecal bile acid profile by gut microbiota in cirrhosisGenta Kakiyama, William M Pandak, Patrick M Gillevet, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 27, 2014
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and functionJasmohan S Bajaj, I Jane Cox, Naga S Betrapally, et al.
Plos One|April 9, 2013
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathyJasmohan S Bajaj, Douglas M Heuman, Arun J Sanyal, et al.
Hepatology (Baltimore, Md.)|June 21, 2019
Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal TransplantRunping Liu, Jason D Kang, R Balfour Sartor, et al.
World Journal of Gastroenterology|December 8, 2025
Bile acid dysmetabolism in Bangladeshi infants associated with poor linear growth, enteric inflammation, and small intestine bacterial overgrowthFarah Hasan, Phillip B Hylemon, Rashidul Haque, et al.
Pageof 13